Clinmedica Research sp. z o.o.

Skierniewice 96-100

0 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Prevention of Stroke or Systemic Embolism, SARS-CoV-2 Infection, Severe Hypertriglyceridemia

Studies at this site

• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early